This study aimed to investigate the IL-23/IL-17 axis cytokine levels of both plasma and liver tissue in patients with different stages of CHC and NASH in order to elucidate the immunopathogenesis of these liver diseases. This evidence concerns the gene IL23A and liver disorder.